Generic Labeling Reg Could Improve Sameness With Brand, FDA’s Woodcock Says
This article was originally published in The Pink Sheet Daily
Executive Summary
House hearing illustrates the strange alliances the proposed rule has produced – Republicans standing with the generic industry in opposition to the reg – and allows FDA to offer a spirited defense of the origins of the policy.